A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine

NCT06147622 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: Prazosin + cyproheptadine
DRUG: KT110

Sponsor

Kinnov Therapeutics